Post Profile






NIH grants MU $3 million to develop new hepatitis B treatments

(University of Missouri-Columbia) Currently, treatment for hepatitis B infections is limited to one class of drugs that targets the virus. Stefan Sarafianos, an investigator with the University of Missouri Bond Life Sciences Center (BLSC) recently was awarded $3 million from the National Institutes of Health to study the disease. Building on existing research, he and his team will work on the development of new drugs to treat HBV.
read more

share

Related Posts


UNC Receives NIH Grant to Develop and Test New Drugs to Block HIV Infection

Health : Newswise Medical News

Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission o...

Georgia State Researcher Gets $2.83 Million Grant To Develop Drugs for Prevention, Treatment of RSV Infection

Health : Newswise Medical News

Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV)...

Discovery Helps UAMS Researcher Land $1.8 Million NIH Grant for Herpes Virus and Cancer Research

Health : Newswise Medical News

A surprise discovery that could lead to new treatments for herpes viruses that infect more than 90 percent of the world's adult population has led to a $1.8 million grant to the University of Arkansas for Medical Sciences (UAMS) fro...

NIH Grants MU $3 Million to Develop New Hepatitis B Treatments

Health : Newswise Medical News

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure. According to the World Health Organization, an estimated 2 billion people currently are infected with HBV, which is mo...

Scientists Have Discovered A "Switch" In The Hepatitis C Virus Which Could Be Used As A Target For New Kinds Of Drug Treatment

Health : Medical News Today

Hepatitis C affects more than 170 million people worldwide, but current combination treatment is only effective against a limited range of this naturally highly variable virus. However, according to new research by the University of...

Comments


Copyright © 2016 Regator, LLC